Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: A randomized controlled trial

JAMA

Volumn 280, Issue 12, 1998, Pages 1074-1079

  Holt, Peter R ^a,c   Atillasoy, Evren O ^a   Gilman, Jody ^a   Guss, Janet ^a   Moss, Steven F ^a   Newmark, Harold ^b   Fan, Kunhua ^b   Yang, Kan ^b   Lipkin, Martin ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b STRANG CANCER PREVENTION CENTER   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYTOKERATIN; MUCIN; SIALOMUCIN; SULFOMUCIN; THYMIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALCIUM INTAKE; CANCER RISK; CELL PROLIFERATION; CLINICAL TRIAL; COLON MUCOSA; COLON POLYP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAIRY PRODUCT; FEMALE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; POLYPECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032581924     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.12.1074     Document Type: Article

References (41)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin. 1997;47:5-27.
2. Lipkin M, Newmark H, Kelloff G. Calcium, Vitamin D and Colon Cancer. Boca Raton, Fla: CRC Press Inc; 1991.
3. Garland CF, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet. 1985;8424:307-309.
4. Slattery M, Sorenson A, Ford M. Dietary calcium intake as a mitigating factor in colon cancer. Am J Epidemiol. 1988;128:504-514.
5. Lipkin M, Newmark H. Development of clinical chemoprevention trials. J Natl Cancer Inst. 1995; 87:1275-1277.
6. Lapre JA, De Vries HT, Van der Meer R. Dietary calcium phosphate inhibits cytotoxicity of fecal water. Am J Physiol. 1991;261:G907-G913.
7. Lapre JA, De Vries HT, Termont DSML, et al. Mechanism of the protective effect of supplemental dietary calcium on cytolytic activity of fecal water. Cancer Res. 1993;53:248-253.
8. Welberg JWM, Kleibeuker JH, Van der Meer R, et al. Effects of oral calcium supplementation on intestinal bile acids and cytolytic activity of fecal water in patients with adenomatous polyps of the colon. Eur J Clin Invest. 1993;23:63-68.
9. 3. Carcinogenesis. 1988; 9:187-190.
10. Morson BC. The polyp-cancer sequence in tne large bowel. Proc R Soc Med. 1974;67:451.
11. Fleiss J. The Design and Analysis of Clinical Experiments. New York, NY: John Wiley & Sons Inc; 1986:49-51.
12. Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med. 1985;313:1381-1384.
13. Richter F, Newmark HL, Richter A, et al. Inhibition of Western diet-induced hyperproliferation and hyperplasia in mouse colon by two sources of calcium. Carcinogenesis. 1995;16:2685-2689.
14. Yang K, Fan K, Newmark H, et al. Cytokeratin, lectin, and acidic mucin modulation in differentiating colonic epithelial cells of mice after feeding Western-style diets. Cancer Res. 1996;56:4644-4648.
15. Garin-Chesa P, Teting WJ, Melamed MR. Expression of cytokeratins in normal and neoplastic colonic epithelial cells: implications for cellular differentiation and carcinogenesis. Am J Surg Pathol. 1986;10:829-835.
16. Filipe MT, Branfoot BM. Abnormal patterns of mucus secretion in apparently normal mucosa of large intestine with carcinoma. Cancer. 1974;34:282-290.
17. Weisburger J, Horn C. The causes of cancer. In: Holleb A, Fink D, Murphy G, eds. American Cancer Society Textbook of Clinical Oncology. Atlanta, Ga: American Cancer Society; 1991.
18. Pence BC, Dunn DM, Zhao C, et al. Protective effects of calcium from nonfat dried milk against colon carcinogenesis in rats. Nutr Cancer. 1996;25: 35-45.
19. Bostick RM, Fosdick L, Wood JR, et al. Calcium normalizes distribution of proliferating cells in colorectal mucosa of sporadic adenoma patients: a randomized double-blinded, placebo-controlled clinical trial. J Natl Cancer Inst. 1995;87:1307-1315.
20. Duris I, Hruby D, Pakarkova B, et al. Calcium chemoprevention in colorectal cancer. Hepatogastroenterology. 1996;43:152-154.
21. Newmark H, Young C. Butyrate and phenylacetate as differentiating agents: practical problems and opportunities. J Cell Biochem. 1995;22:247-253.
22. D'Argenio G, Cosenza V, Delle Cave M, et al. Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology. 1996;110:1727-1734.
23. Schmelz E, Dillehay D, Webb S, et al. Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res. 1996;56:4936-4941.
24. Liew C, Schut HAJ, Chin SF, Pariza MW, Dashwood RH. Protection of conjugated linoleic acid against 2-amino-3-methylimidazo[4,5-f] quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis. 1995;16: 3037-3043.
25. Covers MJAP, Termont DSML, Lapre JA, et al. Calcium in milk products precipitates intestinal fatty acids and secondary bile acids and thus inhibits colonic cytotoxicity in humans. Cancer Res. 1996; 56:3270-3275.
26. Holt PR, Moss SF, Whelan R, et al. Fecal and rectal mucosal diacyglycerol concentrations and epithelial proliferative kinetics. Cancer Epidemiol Biomarkers Prev. 1996;5:937-940.
27. Abdelali H, Cassand P, Soussotte V, et al. Antimutagenicity of components of dairy products. Mutat Res. 1995;331:133-141.
28. Lipkin M. Biomakers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res. 1988;48:235-245.
29. Lipkin M, Newmark H. Development of clinical chemoprevention trials. J Natl Cancer Inst. 1995; 87:1275-1277.
30. Arends JW, Bosman FT, Hilgers J. Tissue antigens in large-bowel carcinoma. Biochem Biophys Res Commun. 1985;780:1-19.
31. Sun TT, Eichner R, Schermer A, Cooper D, Nelson WG, Weiss RA. Classification, expression and possible mechanisms of evolution of mammalian epithelial keratins: a unifying model. In: Levine A, Topp G, Vande Woide G, Watson JD, eds. Cancer Cells: The Transformed Phenotype. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1984.
32. Cooper D, Schermer A, Sun TT. Classification of human epithelial cells and their neoplasms using monoclonal antibodies to keratins: strategies, applications and limitations. Lab Invest. 1985;52: 243-256.
33. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalogue of human cytokeratins: patterns of expression in normal epithelial tumors and cultured cells. Cell. 1982;31:11-24.
34. Sams JS, Lynch HT, Burt RW, Lanspa SJ, Boland CR. Abnormalities of lectin histochemistry in familial polyposis coli and hereditary nonpolyposis colorectal cancer. Cancer. 1990;66:502-508.
35. Hanski C, Sheehan J, Kiehntopf M, Stolze B, Stein H, Riecken EO. Increased number of accessible sugar epitopes defined with monoclonal antibody AM-3 on colonic mucins is associated with malignant transformation of colonic mucosa. Cancer Res. 1991;51:5342-5347.
36. Verhest A, Kiss R, d'Olne D, et al. Characterization of human colorectal mucosa, polyps, and cancers by means of computerized morphonuclear image analysis. Cancer. 1990;65:2047-2054.
37. Ambros RA, Pawel BR, Meshcheryakov I, Kotrosios J, Lambet WC, Trost RC. Nuclear morphometry as a prognostic indicator in colorectal carcinoma dissected for cure. Anal Quant Cyto Histol. 1990;12:172-176.
38. Meling GI, Rognum TO, Clausen OPF, et al. Association between DNA ploidy pattern and cellular atypia in colorectal carcinomas: a new clinical application of DNA flow cytometric study. Cancer. 1991; 67:1642-1649.
39. Vital and Health Statistics of the Centers for Disease Control and Prevention/National Center for Health Statistics. Third National Health and Nutrition Examination Survey, Phase 1, 1988-91: Advance Data. Atlanta, Ga: Centers for Disease Control and Prevention; 1994:255.
40. Baron JA, Beach M. A randomized trial of calcium supplementation to prevent colorectal adenomas [abstract]. Gastroenterology. 1998;114:A563.
41. National Institutes of Health. Optimal calcium intake. In: NIH Consensus Statement. Bethesda, Md: National Institutes of Health;1994;12:1-31.